Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126164071 | 12616407 | 1 | I | 20160718 | 20160802 | 20160802 | EXP | FR-GLAXOSMITHKLINE-FR2016GSK111359 | GLAXOSMITHKLINE | 0.00 | F | Y | 0.00000 | 20160802 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126164071 | 12616407 | 1 | PS | Lamivudine. | LAMIVUDINE | 1 | N | 20564 | |||||||||||
| 126164071 | 12616407 | 2 | SS | VIREAD | TENOFOVIR DISOPROXIL FUMARATE | 1 | N | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126164071 | 12616407 | 1 | Product used for unknown indication |
| 126164071 | 12616407 | 2 | HIV infection |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126164071 | 12616407 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126164071 | 12616407 | Coma | |
| 126164071 | 12616407 | Hepatic failure | |
| 126164071 | 12616407 | Renal failure | |
| 126164071 | 12616407 | Resuscitation | |
| 126164071 | 12616407 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |